Australia's Mesoblast jumps most in 2 months on capital raise

Mesoblast

30/09/2024 05:14

** Shares of Mesoblast  MSB.AX  rise as much as 4.4% to
A$1.1750, their highest levels since July 25
    ** The biotechnology firm enters into a convertible note
subscription agreement to raise $50 mln with its largest
shareholder Gregory George
    ** Says issue price of A$1.32 per share is at a ~17%
premium, as of co's last trading price on Sept 27
    ** MSB stock up 270.9% YTD, including current session's
moves 

    

 (Reporting by Kumar Tanishk in Bengaluru)
 ((Tanishk.Kumar@thomsonreuters.com;))